FDA Nod For MRK's Antibiotic; DRRX Awaits Big Day In Dec., Airxpanders Goes Bust

Today's Daily Dose brings you news about FDA approval of Merck's antibiotic; Durect's upcoming regulatory catalyst; stock offering of Amarin and bankruptcy filing of Airxpanders.

from RTT - Biotech https://ift.tt/2O30R5j
via IFTTT